Amphastar Pharmaceuticals (AMPH) Revenue Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Revenue Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 945.33 Mn | 655.21 Mn | 93.47 Mn | 5.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.44% |
| Mar 31, 2026 | 0.38% |
| Dec 31, 2025 | -1.83% |
| Sep 30, 2025 | 0.33% |
| Jun 30, 2025 | -4.38% |
| Mar 31, 2025 | -0.76% |
| Dec 31, 2024 | 4.73% |
| Sep 30, 2024 | 5.90% |
| Jun 30, 2024 | 25.17% |
| Mar 31, 2024 | 22.72% |
| Dec 31, 2023 | 31.91% |
| Sep 30, 2023 | 50.30% |
| Jun 30, 2023 | 18.02% |
| Mar 31, 2023 | 16.33% |
| Dec 31, 2022 | 11.69% |
| Sep 30, 2022 | 7.07% |
| Jun 30, 2022 | 21.45% |
| Mar 31, 2022 | 16.84% |
| Dec 31, 2021 | 26.03% |
| Sep 30, 2021 | 34.48% |